Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Nov 8;77(19):1718-24.
doi: 10.1212/WNL.0b013e318236eee6. Epub 2011 Oct 12.

Transient ischemic attacks characterized by RNA profiles in blood

Affiliations
Randomized Controlled Trial

Transient ischemic attacks characterized by RNA profiles in blood

X Zhan et al. Neurology. .

Abstract

Objective: Transient ischemic attacks (TIA) are common. Though systemic inflammation and thrombosis are associated with TIA, further study may provide insight into TIA pathophysiology and possibly lead to the development of treatments specifically _targeted to TIA. We sought to determine whether gene expression profiles in blood could better characterize the proinflammatory and procoagulant states in TIA patients.

Methods: RNA expression in blood of TIA patients (n = 26) was compared to vascular risk factor control subjects without symptomatic cardiovascular disease (n = 26) using Affymetrix U133 Plus 2.0 microarrays. Differentially expressed genes in TIA were identified by analysis of covariance and evaluated with cross-validation and functional analyses.

Results: Patients with TIA had different patterns of gene expression compared to controls. There were 480 probe sets, corresponding to 449 genes, differentially expressed between TIA and controls (false discovery rate correction for multiple comparisons, p ≤ 0.05, absolute fold change ≥1.2). These genes were associated with systemic inflammation, platelet activation, and prothrombin activation. Hierarchical cluster analysis of the identified genes suggested the presence of 2 patterns of RNA expression in patients with TIA. Prediction analysis identified a set of 34 genes that discriminated TIA from controls with 100% sensitivity and 100% specificity.

Conclusion: Patients with recent TIA have differences of gene expression in blood compared to controls. The 2 gene expression profiles associated with TIA suggests heterogeneous responses between subjects with TIA that may provide insight into cause, risk of stroke, and other TIA pathophysiology.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Hierarchical cluster analysis of identified genes in transient ischemic attack (TIA) vs matched vascular risk factor controls
Hierarchical cluster analysis of 480 gene probe sets differentially expressed in blood between patients with TIA and control subjects (false discovery rate ≤0.05, absolute fold change >1.2). Each column on the x-axis represents 1 patient, with 26 patients with TIA (blue) and 26 controls (orange). Each row on the y-axis represents individual probe sets (usually for individual genes). TIAs cluster separately from controls as indicated by the green arrow (top). Within subjects with TIA, at least 2 clusters are apparent as indicated by the red arrow. These 2 TIA clusters are labeled TIA1 and TIA2. One patient with TIA (ID: IT-062) clustered with controls. Two controls (ID: IT-155 and IT-177) clustered with TIAs. Diagnosis = blue (TIA) and orange (controls). Green = downregulation; ID = subject ID; Red = upregulation.
Figure 2
Figure 2. Predicted probability of transient ischemic attack (TIA) or control diagnosis based on a linear discriminant analysis (LDA) model
The LDA model was used to derive the 34 genes that optimally distinguished TIA from controls. Probabilities are based on 10-fold leave-one-out cross-validation analysis. The probability of predicted diagnosis is shown on the y-axis, and subjects are shown on the x-axis. Patients with TIA are shown on the right, and control subjects on the left. The predicted probability of TIA is shown in red, and the predicted probability of control is shown in blue. Patients with TIA could be distinguished from controls with 100% sensitivity and 100% specificity.

Comment in

  • Blood markers in TIA: array of hope?
    Cucchiara B, Nyquist P. Cucchiara B, et al. Neurology. 2011 Nov 8;77(19):1716-7. doi: 10.1212/WNL.0b013e318236f110. Epub 2011 Oct 12. Neurology. 2011. PMID: 21998315 No abstract available.

Similar articles

Cited by

  • Bacterial lipopolysaccharide is associated with stroke.
    Hakoupian M, Ferino E, Jickling GC, Amini H, Stamova B, Ander BP, Alomar N, Sharp FR, Zhan X. Hakoupian M, et al. Sci Rep. 2021 Mar 22;11(1):6570. doi: 10.1038/s41598-021-86083-8. Sci Rep. 2021. PMID: 33753837 Free PMC article.
  • Whole genome expression of cellular response to stroke.
    Sharp FR, Jickling GC. Sharp FR, et al. Stroke. 2013 Jun;44(6 Suppl 1):S23-5. doi: 10.1161/STROKEAHA.112.679357. Stroke. 2013. PMID: 23709718 Free PMC article. Review. No abstract available.
  • Acute Stroke Biomarkers: Are We There Yet?
    Dagonnier M, Donnan GA, Davis SM, Dewey HM, Howells DW. Dagonnier M, et al. Front Neurol. 2021 Feb 5;12:619721. doi: 10.3389/fneur.2021.619721. eCollection 2021. Front Neurol. 2021. PMID: 33633673 Free PMC article. Review.
  • Circulating microRNAs as biomarkers of acute stroke.
    Sepramaniam S, Tan JR, Tan KS, DeSilva DA, Tavintharan S, Woon FP, Wang CW, Yong FL, Karolina DS, Kaur P, Liu FJ, Lim KY, Armugam A, Jeyaseelan K. Sepramaniam S, et al. Int J Mol Sci. 2014 Jan 20;15(1):1418-32. doi: 10.3390/ijms15011418. Int J Mol Sci. 2014. PMID: 24447930 Free PMC article.
  • Blood Biomarkers for Stroke Diagnosis and Management.
    Kamtchum-Tatuene J, Jickling GC. Kamtchum-Tatuene J, et al. Neuromolecular Med. 2019 Dec;21(4):344-368. doi: 10.1007/s12017-019-08530-0. Epub 2019 Mar 4. Neuromolecular Med. 2019. PMID: 30830566 Free PMC article. Review.

References

    1. Johnston SC, Nguyen-Huynh MN, Schwarz ME, et al. National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol 2006;60:301–313 - PubMed
    1. Rothwell PM, Buchan A, Johnston SC. Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol 2006;5:323–331 - PubMed
    1. Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease: the American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009;40:2276–2293 - PubMed
    1. Zhan X, Ander BP, Jickling G, et al. Brief focal cerebral ischemia that simulates transient ischemic attacks in humans regulates gene expression in rat peripheral blood. J Cereb Blood Flow Metab 2010;30:110–118 - PMC - PubMed
    1. Zhan X, Kim C, Sharp FR. Very brief focal ischemia simulating transient ischemic attacks (TIAs) can injure brain and induce Hsp70 protein. Brain Res 2008;1234:183–197 - PMC - PubMed

Publication types

  NODES
Association 3
twitter 2